Introduction {#s1}
============

An adequate visual field is one of the most basic requirements for drivers for safe driving in addition to visual acuity. Patients with visual field defects have difficulty safely assessing traffic, following other vehicles, staying in their lane, noticing stoplights, hazards, pedestrians or other vehicles on the road and performing other driving tasks.[@R1] [@R2] Progressive optic neuropathy in diseases such as glaucoma often cause various types of visual field defect that do not affect central visual acuity.[@R3] Many patients with visual field defects, even those with severe defects, are thus able to pass visual acuity tests and receive or retain their driving licences. However, these patients have an increased risk of motor vehicle collisions (MVCs), as has been shown in previous studies based on real-world collisions.[@R4]

Although each MVC has different circumstances, such as the failure to notice traffic signals or stop signs, the sudden appearance of children or vehicles, or vehicles turning into the path of the driver, the degree of this risk may depend on the specific area of the visual field that is affected. Furthermore, every patient with glaucoma suffers from a unique pattern of visual field defects.[@R12] It is therefore challenging to obtain clear information on the individual risks faced by drivers with glaucoma. In fact, previous studies, including our own preliminary study, have yielded conflicting results on which areas of the visual field are related to MVC involvement.[@R11] [@R13]

The key merit of studies based on driving simulator (DS) systems, in comparison with studies based on real-world MVC history and on-road driving, is that they include collisions. This allows us to directly investigate the factors associated with the collisions. DS systems have been used in previous studies to investigate the influence of visual field defects on driving ability,[@R16] and the reliability of these systems has been confirmed by comparing their results with those obtained from on-road testing.[@R20] [@R21] Moreover, DS systems can investigate the effects of different configurations of visual field defects on the ability to avoid MVCs under standardised conditions. In this study, which included a large number of patients, we performed testing with a single, particularly dangerous type of driving scenario, in which an oncoming car at an intersection turned into the driver\'s path. Thus, taking advantage of the controlled conditions of a DS, this study investigated the role of specific visual subfields in a single type of collision.

Materials and methods {#s2}
=====================

Subjects {#s2a}
--------

We included normal subjects and patients with advanced glaucoma, diagnosed as mean deviation (MD) values in both eyes of \<−12 dB, measured with the Humphrey Visual Field Analyzer Swedish Interactive Threshold Algorithm standard 24-2 (HFA 24-2, Carl Zeiss Meditec, Dublin, California, USA). All participants were active drivers who had driven within at least the previous three months. All patients were examined at the Department of Ophthalmology of Jichi Medical University, the Tajimi Iwase Eye Clinic, the Department of Ophthalmology of Kanazawa University and the Department of Ophthalmology of Niigata University between September 2010 and July 2012 under identical conditions. To minimise bias arising from age, only subjects younger than 70 years old were included.

Before using the DS, all participants completed a questionnaire to determine their (1) age and sex, (2) driving habits and history (years since acquisition of first driving licence, time spent driving per week and motor vehicle accident (MVA) involvement over the previous 5 years) and (3) current illnesses and medical history. They also had a complete ophthalmological examination, including best-corrected visual acuity, a slit-lamp examination, intraocular pressure measurement with Goldmann applanation tonometry, gonioscopy, a stereoscopic fundus examination and standard automated perimetry with the HFA 24-2. We excluded those with cataract or other non-glaucoma ocular diseases that could cause visual field defects after a basic ophthalmic examination. We also excluded patients with a history of systemic or neurological disease that could reduce the ability to drive or could affect the visual field, based on self-reporting during patient interviews. Eyes with unreliable visual field results (fixation loss \>20%, false-positive rate \>15% or false-negative rate \>33%) were also excluded.

Integrated visual field {#s2b}
-----------------------

The binocular integrated visual field (IVF) was calculated by merging the results of monocular HFA 24-2 tests from each eye using the points with the higher sensitivity from each test.[@R22] [@R23] Fifty-two test points were included, each representing a 6°×6° IVF subfield.

In the advanced glaucoma group, we evaluated mean IVF sensitivity in the central area of the inferior and superior hemifields within 0°--12° (IVF~0--12~) and within 13°--24° (IVF~13--24~) of the fixation point.[@R24] We also divided the IVF within 0°--12° of the fixation point into six clusters (VF~A,\ B,\ C,\ D,\ E,\ F~) ([figure 1](#BJOPHTHALMOL2016308754F1){ref-type="fig"}).[@R24] We then compared mean sensitivity in each IVF area and each IVF cluster in the patients who were and were not involved in collisions.

![Test point clusters (A--F) located within the central 0°--12°. The location of integrated visual field (IVF) test points was within 0°--12° (IVF~0--12~) and 13°--24° (IVF~13--24~) of the fixation point in both the superior and inferior hemifields. The test points within 0°--12° were divided into six clusters (VF~A~, VF~B~, VF~C~, VF~D~, VF~E~ and VF~F~).](bjophthalmol-2016-308754f01){#BJOPHTHALMOL2016308754F1}

Driving simulator {#s2c}
-----------------

The DS, previously described in detail,[@R13] used a revised version of the Honda Safety Navi (Honda Motor, Tokyo) system (right-hand drive version). The examinees undertook a 2 min practice session followed by the 5 min main test. The only requirement was for the examinee to brake when he or she felt it was necessary. If an examinee reported feeling simulator sickness during the practice session, further testing was immediately abandoned. The main test contained 14 scenarios depicting such situations as coming to a stop sign, traffic light or road hazard, or a child suddenly rushing out in front of the car. In this study, we focused on two scenarios depicting oncoming right-turning cars at an intersection. We recorded the number of collisions in these two scenarios. [Figure 2](#BJOPHTHALMOL2016308754F2){ref-type="fig"} shows a screenshot of the simulation. The yellow line shows the hazard\'s track.

![Screenshot of a simulated scenario. In the screenshots, the yellow line indicates the track of the hazard across the image. The driver\'s vehicle had a simulated speed of 50 km/hour. A blue car ahead of the vehicle turns right into its path. The car appears 10° right of centre and moves left.](bjophthalmol-2016-308754f02){#BJOPHTHALMOL2016308754F2}

Statistical analysis {#s2d}
--------------------

Differences in demographic characteristics between the normal subjects and patients with glaucoma, as well as between the patients with glaucoma who were or were not involved in collisions, were determined using the t-test, χ^2^ test and the Mann-Whitney U test. We also performed a multivariate logistic regression analysis in the patients with advanced glaucoma. The dependent parameter was collision involvement, and the independent parameters were age, visual acuity and mean sensitivity of the IVF subfields (analysis 1: the superior and inferior IVF~0--12~; analysis 2: the superior and inferior IVF~13--24~). All statistical analyses were made with JMP V.9.0. p Values \<0.05 were considered statistically significant.

Results {#s3}
=======

The study included 43 normal subjects and 100 patients with advanced glaucoma. None of the normal subjects experienced simulator sickness. Also, 5 of the 100 patients with advanced glaucoma completed the practice session but experienced simulator sickness during the main test and were excluded. In total, 43 normal subjects (26 males and 17 females) and 95 patients with glaucoma (66 males and 29 females) completed the main test of the DS. There were no differences between the advanced glaucoma and normal control groups in sex or driving history, including hours of driving exposure and number of MVAs in the previous 5 years. The patients with advanced glaucoma were older than the normal subjects (p=0.022) and had more years of driving experience (p=0.048) ([table 1](#BJOPHTHALMOL2016308754TB1){ref-type="table"}). The proportion of subjects who were involved in at least one collision was significantly higher in the advanced glaucoma group (76 of 95 patients; 80%) than the normal group (11 of 43 subjects; 26%) in the two DS scenarios with oncoming right-turning cars (χ^2^ test, p\<0.001).

###### 

Comparison of demographic, driving and vision characteristics of study participants by group

  -----------------------------------------------------------------------------
  Characteristics                  Normal control\   Glaucoma\    p Value
                                   (n=43)            (n=95)       
  -------------------------------- ----------------- ------------ -------------
  Demographic                                                     

   Age (years)                     53.8±8.5          57.4±7.7     0.022^†^

   Gender (male/female)            26/17             66/29        0.298^†^

  Driving                                                         

   Driving years                   30.8±9.8          34.3±8.5     0.048^\*^

   Driving exposure (hours/week)   9.9±11.0          6.5±7.2      0.074^\*^

   Number of MVAs by group         5 (11.3%)         17 (17.9%)   0.455^‡^

  Visual acuity                                                   

   Better-eye logMAR               −0.04±0.08        −0.08±0.03   \<0.001^\*^

   Worse-eye logMAR                −0.07±0.07        0.17±0.38    \<0.001^\*^

  HFA 24-2 MD (dB)                                                

   Better-eye MD                   0.36±1.0          −18.19±4.7   \<0.001§

   Worse-eye MD                    −0.34±1.1         −22.63±4.9   \<0.001§

  IVF sensitivity (dB)                                            

   Superior                        31.0±1.3          13.9±7.3     \<0.001§

   Inferior                        32.0±1.0          18.1±7.0     \<0.001§
  -----------------------------------------------------------------------------

Values are mean±SD.

\*p indicates unpaired t-test.

†p indicates χ^2^ test.

‡p indicates Fisher\'s exact test.

§p indicates Mann-Whitney U test.

HFA, Humphrey Visual Field Analyzer; IVF, integrated visual field; logMAR, logarithm of the minimum angle of resolution; MD, mean deviation; MVA, motor vehicle accident.

Among the normal subjects, there were no significant differences between the subjects involved in one or more collisions (n=11) or no collisions (n=32) in age, sex, driving history (including driving experience, hours of driving exposure and number of MVAs in the previous 5 years), visual acuity or MD value. On the other hand, the patients with advanced glaucoma who were involved in one or more collisions (n=76) were older (p=0.050) and had worse visual acuity in the better eye than those who were not involved in collisions (n=19) (p\<0.001). The mean sensitivity of the inferior IVF~0--12~ and inferior IVF~13-24~ was also significantly lower in the patients with glaucoma involved in collisions than those not involved in collisions (p=0.012 and p=0.034, respectively) ([table 2](#BJOPHTHALMOL2016308754TB2){ref-type="table"}). Our analysis in the patients with advanced glaucoma of IVF clusters within 0°--12° of the fixation point showed that there were clear differences between the collision-involved and collision-uninvolved patients in mean sensitivity in VF~E~ (p=0.024) and VF~F~ (p=0.041). On the other hand, there were no significant differences between the two groups in VF~D~ and in the superior paracentral clusters, that is, VF~A~, VF~B~ and VF~C~ ([table 2](#BJOPHTHALMOL2016308754TB2){ref-type="table"}).

###### 

Comparison of demographic, driving and vision characteristics of collision-involved and collision-uninvolved patients

                                        Normal control (n=43)                Glaucoma (n=95)                             
  ------------------------------------- ----------------------- ------------ ----------------- ------------ ------------ -----------
  Demographic                                                                                                            
   Age (years)                          53.8±8.0                53.2±9.6     0.804\*           53.9±8.4     58.2±7.3     0.050\*
   Sex (male/female)                    20/12                   5/6          0.480†            13/6         54/22        0.786†
  Driving                                                                                                                
   Driving experience (years)           30.8±9.9                30.7±10.1    0.990\*           32.8±9.1     34.6±8.3     0.441\*
   Driving exposure time (hours/week)   9.8±10.2                6.0±7.8      0.526\*           9.8±10.2     6.0±7.8      0.116\*
   Number of MVAs                       3 (9.4%)                2 (18.1%)    0.589†            4 (21.1%)    13 (17.1%)   0.740†
  Mean visual acuity (logMAR)                                                                                            
   Better eye                           −0.08±0.02              −0.07±0.03   0.240\*           −0.09±0.04   −0.03±0.08   \<0.001\*
   Worse eye                            −0.07±0.03              −0.03±0.12   0.358\*           0.17±0.42    0.17±0.38    0.978\*
  HFA 24-2 mean deviation (dB)                                                                                           
   Better eye                           0.36±1.0                −0.19±0.8    0.133‡            −16.2±3.3    −18.70±4.9   0.055‡
   Worse eye                            −0.34±1.1               −1.0±1.0     0.132‡            −21.1±4.5    −23.01±5.0   0.132‡
  IVF mean sensitivity (dB)                                                                                              
   Superior IVF~0--12~                  33.1±0.7                32.4±1.3     0.318‡            15.3±9.6     12.2±9.3     0.221‡
   Inferior IVF~0--12~                  31.5±0.9                32.7±1.4     0.340‡            23.9±6.1     18.6±8.8     0.012‡
   Superior IVF~13--24~                 30.3±1.3                29.6±0.9     0.205‡            15.5±8.0     13.9±7.3     0.500‡
   Inferior IVF~13--24~                 31.6±0.9                31.3±1.1     0.589‡            20.7±6.2     16.9±7.4     0.034‡
  IVF sectors mean sensitivity (dB)                                                                                      
   VF~A~                                                                                       9.2±10.9     9.0±10.8     0.772‡
   VF~B~                                                                                       15.5±12.1    12.0±10.6    0.237‡
   VF~C~                                                                                       21.3±9.2     15.7±11.5    0.096‡
   VF~D~                                                                                       24.2±6.9     20.1±9.6     0.086‡
   VF~E~                                                                                       27.3±6.3     22.1±9.8     0.024‡
   VF~F~                                                                                       20.2±9.9     13.6±11.7    0.041‡

Values are mean±SD.

\*p indicates unpaired t-test.

†p indicates Fisher\'s exact test.

‡p indicates Mann-Whitney U test.

DS, driving simulator; HFA, Humphrey Visual Field Analyzer; IVF, integrated visual field; logMAR, logarithm of the minimum angle of resolution; MVA, motor vehicle accident.

We performed two separate logistic regression analyses in the patients with advanced glaucoma for different areas of the IVF. Analysis 1 showed that collision involvement was not significantly associated with mean sensitivity in the superior and inferior IVF~0-12~ (p=0.860, p=0.112), although it was associated with age (p=0.017; OR 1.099; 95% CI 1.016 to 1.202) and better-eye VA (10 logarithm of the minimum angle of resolution (logMAR), p\<0.001; OR 28.59; 95% CI 3.44 to 754.85) ([table 3](#BJOPHTHALMOL2016308754TB3){ref-type="table"}). Analysis 2 showed that collision involvement was significantly associated with mean sensitivity in the inferior IVF~13-24~ (p=0.041; OR 0.910; 95% CI 0.815 to 0.996), as well as age (p=0.018; OR 1.10; 95% CI 1.02 to 1.20) and better-eye VA (10 logMAR, p\<0.001; OR 75.71; 95% CI 6.62 to 2669.40) ([table 3](#BJOPHTHALMOL2016308754TB3){ref-type="table"}).

###### 

Multivariate logistic regression analysis of factors influencing the risk of collisions with oncoming cars during simulated driving, shown as OR with 95% CI (model 1)

  Independent variable         OR\*    95% CI          p Value
  ---------------------------- ------- --------------- ---------
  Analysis 1                                           
   Age (years)                 1.10    1.02--1.20      0.017
   Better-eye 10 logMAR        28.59   3.44--754.85    \<0.001
   Superior IVF~0--12~ (dB)    1.01    0.94--1.07      0.860
   Inferior IVF~0--12~ (dB)    0.94    0.85--1.01      0.112
  Analysis 2                                           
   Age (years)                 1.10    1.02--1.20      0.018
   Better-eye 10 logMAR        75.71   6.62--2669.40   \<0.001
   Superior IVF~12--24~ (dB)   1.04    0.95--1.15      0.347
   Inferior IVF~12--24~ (dB)   0.91    0.82--0.99      0.041

IVF, integrated visual field; logMAR, logarithm of the minimum angle of resolution.

Discussion {#s4}
==========

In this study, we attempted to investigate the association of visual field defects with collisions with oncoming right-turning cars by testing patients with advanced glaucoma in a DS. Our results indicated that lower mean sensitivity in the inferior IVF hemifield contributed significantly to MVCs with oncoming right-turning cars in a DS.

Recently, a number of studies have described the importance of determining which areas of the visual field are associated with MVC involvement. Huisingh *et al*[@R14] reported that drivers with a severely impaired lower or left field were more involved in MVCs, while Glen *et al*[@R15] found that lowered performance in the hazard perception test (a part of UK driving examinations) was more strongly associated with defects in the upper visual field than the lower field. On the other hand, Yuki *et al*[@R12] reported that central VF damage had no effect on MVCs; these studies have yielded conflicting results on which areas of the VF are most likely to be associated with MVCs. In our study, normal subjects who were involved in collisions had no significant differences in age with the subjects who were not involved. However, the subjects with advanced glaucoma had differences in age, visual acuity and visual field sensitivity. Comparing IVF clusters in the patients with advanced glaucoma who were involved and uninvolved in collisions showed that mean sensitivity in the inferior clusters within 12° of the fixation point, and the overall mean sensitivity of the inferior IVF~13--24~, may have contributed to the subjects\' increased involvement in MVCs with oncoming right-turning cars. A logistic regression analysis in the advanced glaucoma revealed that in the DS scenario showing oncoming right-turning cars the number of collisions during simulated driving was significantly associated with decreased inferior IVF~13-24~ mean sensitivity in addition to older age and worse visual acuity.

We focused on scenarios in which an oncoming car at an intersection turned into the driver\'s path because this situation can be very serious. The importance of focusing on specific scenarios is suggested by the existence of laws to prevent elderly people with dementia from driving. For example, the Japanese government recently established a law requiring drivers older than 75 years to undergo cognitive testing if they commit certain characteristic types of traffic violation, such as ignoring signals or driving the wrong way on expressways. There is thus a growing recognition that certain accident types may serve as indicators of specific types of driver impairment. Therefore, validating the contribution of visual field impairment in individuals who are involved in characteristic types of traffic violation (ie, collisions with oncoming cars) is thought to be useful in identifying at-risk subjects in the real-world MVCs.

A strength of this study was the inclusion of patients with advanced glaucoma (MD worse than −12). Many studies have suggested that patients with glaucoma, particularly those with advanced damage, have a greater risk of MVC, but to the best of our knowledge, only one[@R25] has included patients with advanced glaucoma. Driving cessation is an effective way of avoiding the risks associated with visual field loss, but it also negatively affects quality of life and the ability to live with independence. It is therefore important to correctly assess the impact of visual impairment due to glaucoma on the ability of patients to drive safely. Our results suggest that in patients with advanced glaucoma the inferior hemifield IVF was most associated with MVCs with oncoming cars. In glaucoma, the lower central field often remains relatively preserved until the very late stages of the disease.[@R26] The patients with glaucoma in our study followed this pattern: they had better IVF sensitivity in the inferior hemifield than in the superior hemifield. Furthermore, our results showed that in these patients the greatest potential risk of a particular type of MVC, those that occur with oncoming right-turning cars in a DS, was associated with decreases in inferior IVF sensitivity. Thus, our study confirms the importance of the inferior IVF hemifield in patients with advanced glaucoma who continue driving.

Our study had several limitations. First, using a DS has a number of inherent limitations.[@R2] The scenarios shown in the DS differed from real-world situations in ways that may have inflated the number of collisions. Moreover, our study used only one specific type of DS scenario rather than a variety of scenarios showing different situations. Nevertheless, our results were consistent with those of Huisingh *et al*,[@R14] who studied the relationship between MVC involvement and the areas of the visual field used while driving, and found that severe impairment of the lower or left field was associated with MVC involvement. Thus, we believe that our study is a valuable first step towards future, more precise investigations of patterns of visual field impairment that affect the ability to drive safely.

Second, the patients with advanced glaucoma involved in one or more collisions tended to be older than those not involved in collisions (58.2±7.3 vs 53.9±8.4 years, p=0.0503). It is possible that factors associated with increasing age (eg, dementia, age-related decrease in vision, mild cataracts) might have confounded this result. However, our study excluded subjects \>70 years of age in order to minimise effects of these factors. Furthermore, because the univariate analysis revealed a significant association between collision involvement and the inferior IVF, we performed a multivariable logistic regression analysis to separately analyse the influences of age, visual acuity and visual field damage on collisions with oncoming cars in simulated driving. Our results suggested that older patients with glaucoma with more advanced glaucomatous damage in the inferior hemifield and lower visual acuity might benefit from advice to be particularly cautious of oncoming cars. Identification of factors associated with advanced age (\>70 years) awaits further study.

Third, in contrast to previous studies that used eye-tracking devices to study driving performance, our study used an assumed fixation point. However, we used a scenario in which an oncoming car at an intersection turned into the driver\'s path, which is a type of MVC that occurs while the driver is looking ahead. Thus, we consider that eye movements only minimally influenced our results. Nevertheless, an eye-tracking device will be necessary in future studies including other scenarios, such as hazards coming from the side.

In conclusion, we assessed the relationship of specific visual subfield defects with collisions with an oncoming car, under the controlled conditions provided by a DS, in patients with advanced glaucoma. We found that the inferior visual field, as well as age and visual acuity, was an important factor associated with the ability to safely navigate these specific collision scenarios. Our findings may be useful in creating guidelines for safe driving for patients with glaucoma and for the development of clear warning systems to encourage risky drivers to reconsider driving and avoid potential MVAs.
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